Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹14,476Cr
Rev Gr TTM
Revenue Growth TTM
6.25%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

FINEORG
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -3.3 | -26.8 | -41.2 | -35.7 | -8.3 | 0.5 | 10.2 | 5.8 | 10.9 | 7.0 | 0.3 | 7.3 |
| 394 | 406 | 409 | 370 | 403 | 410 | 445 | 414 | 487 | 465 | 462 | 460 |
Operating Profit Operating ProfitCr |
| 33.9 | 25.8 | 24.3 | 24.2 | 26.3 | 25.4 | 25.3 | 19.9 | 19.7 | 21.0 | 22.6 | 17.0 |
Other Income Other IncomeCr | 12 | 14 | 16 | 16 | 22 | 24 | 21 | 25 | 26 | 46 | 20 | 21 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 |
Depreciation DepreciationCr | 13 | 12 | 14 | 15 | 15 | 12 | 13 | 13 | 15 | 12 | 13 | 14 |
| 201 | 143 | 132 | 119 | 150 | 151 | 159 | 115 | 130 | 157 | 142 | 101 |
| 51 | 43 | 29 | 25 | 35 | 38 | 42 | 32 | 33 | 40 | 33 | 27 |
|
Growth YoY PAT Growth YoY% | 22.6 | -37.6 | -49.0 | -11.3 | -23.4 | 13.5 | 13.6 | -12.2 | -15.2 | 3.4 | -7.6 | -10.6 |
| 25.1 | 18.2 | 19.1 | 19.3 | 20.9 | 20.6 | 19.7 | 16.0 | 16.0 | 19.9 | 18.2 | 13.3 |
| 48.7 | 32.5 | 33.7 | 30.7 | 37.4 | 36.9 | 38.3 | 27.0 | 31.7 | 38.2 | 35.4 | 24.1 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 9.9 | 23.9 | -2.1 | 9.2 | 65.6 | 61.1 | -29.8 | 6.9 | 3.4 |
| 633 | 697 | 830 | 798 | 934 | 1,512 | 2,192 | 1,588 | 1,756 | 1,875 |
Operating Profit Operating ProfitCr |
| 18.6 | 18.5 | 21.7 | 23.2 | 17.6 | 19.4 | 27.5 | 25.2 | 22.6 | 20.1 |
Other Income Other IncomeCr | 4 | 16 | 20 | 15 | 16 | 32 | 62 | 69 | 97 | 113 |
Interest Expense Interest ExpenseCr | 4 | 3 | 2 | 5 | 6 | 5 | 5 | 2 | 2 | 2 |
Depreciation DepreciationCr | 24 | 20 | 17 | 35 | 47 | 40 | 48 | 57 | 52 | 53 |
| 121 | 151 | 231 | 216 | 162 | 352 | 841 | 544 | 555 | 530 |
| 43 | 56 | 95 | 51 | 42 | 92 | 223 | 132 | 145 | 133 |
|
| | 22.4 | 42.9 | 20.9 | -27.0 | 115.8 | 138.0 | -33.4 | -0.3 | -3.4 |
| 10.0 | 11.1 | 12.8 | 15.9 | 10.6 | 13.8 | 20.4 | 19.4 | 18.1 | 16.9 |
| 25.4 | 31.1 | 44.4 | 53.8 | 39.3 | 84.7 | 201.6 | 134.3 | 133.9 | 129.4 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 5 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| 323 | 380 | 485 | 604 | 716 | 944 | 1,526 | 1,906 | 2,280 | 2,462 |
Current Liabilities Current LiabilitiesCr | 116 | 134 | 105 | 134 | 155 | 251 | 265 | 184 | 214 | 170 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 97 | 99 | 61 | 26 | 1 | 2 | 1 | 13 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 281 | 333 | 434 | 524 | 620 | 888 | 1,420 | 1,682 | 1,813 | 2,020 |
Non Current Assets Non Current AssetsCr | 164 | 197 | 268 | 328 | 327 | 348 | 387 | 426 | 697 | 641 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 45 | 65 | 98 | 219 | 134 | 67 | 485 | 635 | 204 |
Investing Cash Flow Investing Cash FlowCr | -16 | -52 | -93 | -85 | -40 | -56 | -85 | -391 | -669 |
Financing Cash Flow Financing Cash FlowCr | -55 | -17 | 92 | -37 | -41 | -68 | -69 | -59 | -34 |
|
Free Cash Flow Free Cash FlowCr | 34 | 25 | 6 | 147 | 88 | 6 | 405 | 549 | 77 |
| 57.9 | 68.3 | 72.2 | 132.9 | 111.6 | 25.6 | 78.5 | 154.1 | 49.7 |
CFO To EBITDA CFO To EBITDA% | 31.1 | 41.1 | 42.8 | 91.1 | 67.4 | 18.3 | 58.4 | 118.7 | 39.8 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 3,791 | 5,831 | 6,999 | 12,309 | 13,205 | 12,358 | 12,247 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 27.8 | 35.4 | 58.2 | 47.4 | 21.4 | 30.0 | 29.8 |
Price To Sales Price To Sales | 0.0 | 0.0 | 3.6 | 5.6 | 6.2 | 6.6 | 4.4 | 5.8 | 5.4 |
Price To Book Price To Book | 0.0 | 0.0 | 7.6 | 9.4 | 9.6 | 12.8 | 8.6 | 6.4 | 5.3 |
| 0.1 | 0.3 | 16.5 | 23.8 | 34.3 | 33.3 | 15.3 | 21.2 | 22.0 |
Profitability Ratios Profitability Ratios |
| 36.1 | 34.8 | 38.2 | 41.3 | 35.9 | 36.7 | 41.0 | 42.7 | 41.5 |
| 18.6 | 18.5 | 21.7 | 23.2 | 17.6 | 19.4 | 27.5 | 25.2 | 22.6 |
| 10.0 | 11.1 | 12.8 | 15.9 | 10.6 | 13.8 | 20.4 | 19.4 | 18.1 |
| 34.0 | 34.4 | 37.9 | 31.1 | 20.5 | 35.0 | 53.9 | 28.4 | 24.3 |
| 23.7 | 24.1 | 27.2 | 26.6 | 16.4 | 27.1 | 40.1 | 21.4 | 17.9 |
| 17.5 | 18.0 | 19.4 | 19.3 | 12.7 | 21.0 | 34.2 | 19.5 | 16.4 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Company Overview**
Fine Organic Industries Ltd. is India’s largest and pioneering manufacturer of **oleochemical-based green specialty additives**, established in 1971 (originally as a partnership firm in 1970). Headquartered in Mumbai, the company has evolved into a globally recognized player with over five decades of leadership in sustainable, plant-derived additive solutions. It serves over **890 direct customers** across **80+ countries**, supported by a network of 240+ distributors and international warehouses in the USA and Europe.
The company became publicly listed in 2017 via an IPO on the BSE and NSE, marking a key milestone in its growth journey.
---
### **Core Business and Product Portfolio**
Fine Organics leverages deep expertise in **oleochemistry**—extracting value from vegetable oils—to develop high-performance, eco-friendly specialty additives used in critical industrial applications. Its diversified portfolio spans over **600 products** across six strategic segments:
1. **Food Additives**
- Emulsifiers, anti-fungal agents, bread improvers, beverage clouding agents.
- Enhance texture, shelf life, and freshness in bakery, dairy, confectionery, ice cream, and oils & fats.
- Pioneered food emulsifiers in India; continues to lead in innovation with natural alternatives.
2. **Polymer Additives**
- Anti-blocking, anti-static, anti-fog, slip, filler dispersants.
- Used in PVC, polyolefins, styrenics, engineering polymers, rubbers, and bioplastics.
- Supports recyclability and circular economy goals.
3. **CosPha (Cosmetics & Pharmaceuticals)**
- Emollients, base ingredients for creams, lotions, ointments, gels.
- Focus on sensory enhancement, stability, and compatibility with active compounds.
- Developed a milder, bio-based surfactant for sensitive skin care (baby shampoos, face washes).
4. **Feed Nutrition Additives**
- Antibiotic alternatives that improve feed efficiency, animal health, and fertility.
- Natural antimicrobials derived from oleochemicals; aligned with global trends in sustainable animal nutrition.
5. **Coatings Additives**
- Anti-settling, emulsifying, thickening, defoaming, biocidal, and anti-mar agents.
- Enhance durability, appearance, and protective properties in industrial coatings, paints, inks.
6. **Specialty & Functional Additives**
- Custom formulations for industrial applications, bitumen, lubricants, and personal care.
- Includes a patented **metal-free antimicrobial additive for PPE and plastic products** developed during the pandemic.
---
### **Key Competitive Advantages**
Fine Organics maintains a strong and defensible market position through a combination of **technology, integration, and customer intimacy**:
- **High Barriers to Entry**:
The green specialty additives industry is capital-intensive, technologically complex, and heavily regulated. Fine Organics’ **proprietary technology**, adherence to global safety/environmental norms (e.g., USDA BioPreferred® certified), and in-house R&D create significant entry barriers.
- **In-House Capabilities**:
- **Integrated R&D and Engineering**: Owns full **end-to-end capabilities**—from concept to commercialization.
- **In-house plant design and equipment manufacturing**: Reduces capex, accelerates commissioning, protects IP, and ensures scalability.
- **Zero-Liquid Discharge (ZLD)** operations across all plants; commitment to energy efficiency and green chemistry principles.
- **Customer Stickiness**:
- Additives are **performance-critical** and require lengthy, costly regulatory approvals.
- Customers exhibit **high loyalty**, often locking into long-term partnerships due to **high switching costs**.
- **Early-Mover Advantage**:
As the **first Indian manufacturer of food emulsifiers**, Fine Organics has built trusted relationships and deep technical know-how, reinforcing its status as a preferred vendor globally.
---
### **Research & Development (R&D)**
R&D is the cornerstone of Fine Organics’ strategy. The company employs a **dedicated team of 35 scientists and technicians** (up from 18 in 2020), supported by:
- A **state-of-the-art R&D center** in Dombivli (relocated from Mahape in 2024).
- Two modern **pilot plants** in Dombivli and Mahape for rapid scale-up.
- A new **operational pilot plant in Dombivli (FY25)** focused on bridging lab innovation to full-scale production.
**R&D Focus Areas**:
- Development of **bio-based, biodegradable** additives.
- Innovations in **food emulsifiers, feed nutrition, coatings, and green polymers**.
- Process optimization, resource efficiency, and carbon footprint reduction.
- Commercialization of **next-gen products**, including specialty molecules with only 2–3 global producers.
The company has achieved **USDA BioPreferred® certification**, validating its commitment to renewable, sustainable chemistry.
---
### **Global Expansion & Manufacturing Strategy**
Fine Organics is executing a transformational global footprint expansion to strengthen supply security, reduce lead times, and serve key markets locally.
#### **New Manufacturing Hubs**
1. **USA Expansion (Fine Organics Americas LLC)**
- Incorporated a **wholly owned subsidiary** in the U.S.
- Acquired **~159.9 acres in Jonesville, South Carolina (Union County)** in July 2025.
- Investment: **USD 1.12 million (INR 9.6 crore)** in June 2025.
- A new **full-scale manufacturing facility** is planned, targeting North, Central, and South America.
- Shift from 12-year-old sales office model to **local production**, improving U.S. compliance, logistics, and competitiveness.
2. **India - Greenfield SEZ Project**
- Signed 60-year lease for **30-acre land in JNPA SEZ, Mumbai** (Nov 2024).
- Project cost: ~**₹750 crores** (debt + internal accruals).
- Dedicated to **export-oriented production**, expected to commence by **late 2027**.
- Will free up domestic capacity for growing local demand.
3. **UAE Subsidiary**
- Being established to enhance **GCC regional presence**, supply chain efficiency, and customer service.
- Focus on **commercial and distribution hub**, with no immediate manufacturing plans (phased approach).
4. **Thailand Joint Venture**
- **Fine Organic Industries (Thailand) Co., Ltd.** — production trials underway.
- Expands access to Southeast Asian markets.
5. **Europe**
- A subsidiary incorporated; supports pan-European distribution.
#### **Domestic Manufacturing**
- **Six fully automated plants** in Maharashtra: Dombivli, Badlapur, Ambernath, Patalganga (2 units), and JNPA SEZ (future).
- All facilities operate at **near full capacity**, reflecting robust demand.
- Strategic proximity to ports enables efficient global logistics.
---
### **Commercial & Financial Highlights (FY25)**
- **Revenue Split**: **57% exports**, 43% domestic – reflecting strong global integration and balanced geographic exposure.
- **Customer Base**:
- 890+ direct customers.
- Over **5,400 end-users** via 240+ distributors globally.
- **Intercompany Revenues**:
- Significant intercompany sales (e.g., INR 1,263 crore to Fine Zeelandia Pvt. Ltd.), indicating strong JV integration.
- Licensing income (INR 140 crore) reflects **intellectual property monetization**.
- **Performance Resilience**:
- Maintained growth despite **geopolitical tensions, raw material volatility, and global logistics disruptions** (e.g., Red Sea crisis).
- Logistics costs normalized in H2 FY25 after elevated H1 levels.
- Implemented process efficiency improvements to counter input cost pressures.
- **Capacity & Demand**:
- Existing plants operating at peak efficiency; Patalganga near full utilization.
- No debottlenecking at Patalganga due to safety concerns—underscoring commitment to **operational safety over quick fixes**.
---
### **Sustainability & Innovation Leadership**
Fine Organics is a leader in **green chemistry** and circular manufacturing:
- Applies **all 12 principles of green chemistry**.
- Uses **natural gas, solar-powered warehouse lighting (Sky pipes), VFDs for energy optimization**.
- **Heat recovery systems** reduce boiler fuel consumption.
- **FT-NIR spectroscopy** in QC labs—reduces chemical use, improves analysis speed and safety.
- Digitized **Tanker Unloading Verification (TuV)** platform enhances traceability and efficiency.
Its products replace hazardous chemicals in plastics, food, and cosmetics—aligning with global ESG trends and regulatory shifts.
---
### **Strategic Growth Pillars**
Fine Organics' long-term strategy is built on four pillars:
1. **New Product Development** – continuous innovation in green additives.
2. **Application Development** – customer-specific technical solutions.
3. **Global Expansion** – local manufacturing in USA, UAE, Thailand, and Europe.
4. **Capacity Enhancement** – greenfield projects in Mumbai SEZ and South Carolina.
---